Commercial Aircraft MRO Market 2014

Commercial Aircraft MRO Market 2014
COMMERCIAL AIRCRAFT MRO MARKET TO BE WORTH $53.4BN IN 2014 London, UK. 30th MAY 2014: New aviation market research published today by leading business intelligence company visiongain has reported that the commercial aircraft MRO market will reach a value of $53.4bn in 2014 as a result of growing demand for maintenance services to handle the ...

SANOFI SAYS FDA TO REVIEW LEMTRADA RESUBMISSION

French drug company Sanofi said 30th May that the FDA had agreed to review its US unit Genzyme’s resubmission of its application for its Lemtrada drug for the treatment of relapsing forms of multiple sclerosis, Reuters reports. A six-month review period has been assigned for the Lemtrada resubmission and Genzyme expects an FDA action in ...

NOVARTIS MUST FACE US GOVERNMENT LAWSUIT ALLEGING DRUG KICKBACKS

A federal judge 29th May refused to dismiss a US government lawsuit accusing Novartis of civil fraud for having conducted two illegal kickback schemes to boost sales of drugs covered by Medicare and Medicaid, Reuters reports. US District Judge Colleen McMahon in Manhattan rejected the argument by Novartis that the lawsuit should be dismissed because ...

REPORT – “HEPATITIS WARRIOR” SHOWS OPPOSITION TO GSK

A 27-year-old activist, who contracted the hepatitis virus as a child from a reused vaccination needle, is planning another round of campaigning, putting the spotlight on GSK, currently under government investigation in China for bribery, Bloomberg reports. Lei Chuang trekked almost 1,000 miles over 80 days from Shanghai to Beijing last summer, along riverbanks and ...

BAYER, ARGEN-X COLLABORATE ON ANTIBODY CANDIDATES

ArGEN-X has announced the initiation of a collaboration with Bayer leveraging arGEN-X’s SIMPLE antibody technology for the discovery and development of therapeutic antibodies, dddmag.com reports. The collaboration centres on a novel approach to addressing complex targets across multiple therapeutic areas that are often intractable by existing antibody platforms. “We are delighted that Bayer, with its ...

MYLAN LAUNCHES ATOVAQUOTE & PROGUANIL HYDROCHLORIDE TABLETS

Mylan has launched atovaquone and proguanil hydrochloride tablets, 62.5 mg/25 mg and 250 mg/100 mg, the generic version of GSK’s Malarone tablets, pharmabiz.com reports. Mylan received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the prophylaxis of plasmodium falciparum malaria and the treatment of ...

BAYER RECEIVES EUROPEAN APPROVAL FOR NEXAVAR IN THYROID CANCER

The EC has expanded the approved uses of Bayer and Amgen unit Onyx Pharma’s Nexavar to treat the most common form of thyroid cancer, pharmabiz.com reports. Specifically, Nexavar (sorafenib), which is already approved for advanced kidney and liver cancers, has received approval for the treatment of metastatic differentiated thyroid carcinoma that is refractory to radioactive ...

PFIZER APPOINTS CSO FOR CV & METABOLIC DISEASE RESEARCH

Pfizer has announced that Dr Morris Birnbaum has joined the company as CSO for Cardiovascular and Metabolic Disease Research, dddmag.com reports. He will report directly to Rod MacKenzie, group SVP and head of PharmaTherapeutics Research & Development, and will be based in a key Pfizer R&D hub in Cambridge, Massachusetts. “As the new leader of ...

ITALY’S NEWRON FILES PARKINSON’S DRUG WITH FDA

Newron Pharma and fellow Italy-headquartered partner Zambon have filed their investigational Parkinson’s disease treatment safinamide with regulators in the US, pharmatimes.com reports. The submission to the FDA is for safinamide as add-on therapy in early and mid-to late stage PD patients. Newron said the filing was based on “completion of activities agreed upon during meetings” ...

INDIA’S ZYDUS CADILA RECALLS OVER 10,000 BOTTLES OF ALLERGY DRUG IN US

Indian drug maker Zydus Cadila is recalling 10,200 bottles of an allergy-relief drug in the US after another drug for high blood pressure was found in one of the bottles, the FDA said 30th May, Reuters reports. The recall was voluntarily started by the company’s US unit, Zydus Pharma, on 8th May, due to the ...